Efficacy and Safety of Once-Daily Tacrolimus in Liver Transplant Recipients (SOUL)

NCT04069065 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

146

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Transplant

Interventions

DRUG: Conversion to Once-daily Tacrolimus

Sponsor

Chong Kun Dang Pharmaceutical